Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$571M |
| 2 |
Medtronic
MDT
|
+$429M |
| 3 |
Citigroup
C
|
+$412M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$408M |
| 5 |
Gilead Sciences
GILD
|
+$397M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.47B |
| 2 |
Amazon
AMZN
|
+$1.35B |
| 3 |
Apple
AAPL
|
+$1.14B |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 5 |
Bank of America
BAC
|
+$718M |
Sector Composition
| 1 | Technology | 16.46% |
| 2 | Healthcare | 15.78% |
| 3 | Consumer Discretionary | 11.75% |
| 4 | Financials | 11.25% |
| 5 | Industrials | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4876
Protalix BioTherapeutics
PLX
$152M
| $93.5K | ﹤0.01% |
91,658
+73,190
| +396% | +$74.7K |
|
4877
Cato Corp
CATO
$90M
| $93.4K | ﹤0.01% |
18,725
-38,257
| -67% | -$191K |
|
4878
ProShares Ultra Technology
ROM
$822M
| $93.3K | ﹤0.01% |
+1,391
| New | +$93.3K |
|
|
EDAP
4879
EDAP TMS
EDAP
$90.1M
| $93.2K | ﹤0.01% |
36,563
+1,527
| +4% | +$3.89K |
|
4880
Rockwell Medical
RMTI
$57.8M
| $93K | ﹤0.01% |
23,421
-80,407
| -77% | -$319K |
|
4881
LM Funding America
LMFA
$19M
| $92.9K | ﹤0.01% |
34,914
+6,986
| +25% | +$18.6K |
|
4882
Gladstone Investment Corp
GAIN
$538M
| $92.7K | ﹤0.01% |
6,416
-14,084
| -69% | -$204K |
|
|
VIOT
4883
Viomi Technology
VIOT
$233M
| $91.8K | ﹤0.01% |
59,243
-4,239
| -7% | -$6.57K |
|
4884
BGSF Inc
BGSF
$84.2M
| $91.7K | ﹤0.01% |
10,891
-6,803
| -38% | -$57.3K |
|
|
DSL
4885
DoubleLine Income Solutions Fund
DSL
$1.43B
| $91.6K | ﹤0.01% |
7,055
-2,631
| -27% | -$34.2K |
|
|
IHTA
4886
DELISTED
Invesco High Income 2024 Target Term Fund
IHTA
| $91.2K | ﹤0.01% |
11,995
+700
| +6% | +$5.32K |
|
4887
Clearside Biomedical
CLSD
$20.7M
| $90.9K | ﹤0.01% |
71,603
-25,027
| -26% | -$31.8K |
|
|
TBNK
4888
DELISTED
Territorial Bancorp Inc.
TBNK
| $90.7K | ﹤0.01% |
8,690
-3,889
| -31% | -$40.6K |
|
4889
Riley Exploration Permian
REPX
$600M
| $90.6K | ﹤0.01% |
3,421
-48,018
| -93% | -$1.27M |
|
|
CTEV
4890
Claritev Corporation
CTEV
$986M
| $90.3K | ﹤0.01% |
11,817
-39,548
| -77% | -$302K |
|
4891
Gogoro
GGR
$96.5M
| $90.2K | ﹤0.01% |
+170,239
| New | +$90.2K |
|
4892
Liberty All-Star Equity Fund
USA
$1.91B
| $89.8K | ﹤0.01% |
12,643
-11,028
| -47% | -$78.3K |
|
4893
Nuveen Preferred & Income Opportunities Fund
JPC
$2.66B
| $89.7K | ﹤0.01% |
+11,119
| New | +$89.7K |
|
4894
iShares MSCI China A ETF
CNYA
$218M
| $89.7K | ﹤0.01% |
2,953
-4,393
| -60% | -$133K |
|
4895
Future FinTech Group
FTFT
$8.07M
| $89.7K | ﹤0.01% |
23,858
+15,469
| +184% | +$58.1K |
|
|
FLNT
4896
Fluent
FLNT
$49.8M
| $89K | ﹤0.01% |
+24,323
| New | +$89K |
|
|
CUTR
4897
DELISTED
Cutera, Inc.
CUTR
| $88.8K | ﹤0.01% |
112,581
+93,438
| +488% | +$73.7K |
|
4898
AdvisorShares Pure Cannabis ETF
YOLO
$41.5M
| $88.7K | ﹤0.01% |
27,192
+7,272
| +37% | +$23.7K |
|
|
IH
4899
iHuman
IH
$157M
| $88.2K | ﹤0.01% |
38,369
-1,349
| -3% | -$3.1K |
|
4900
Strategy Shares Nasdaq 7HANDL Index ETF
HNDL
$682M
| $88.2K | ﹤0.01% |
3,963
-3,437
| -46% | -$76.5K |
|